| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 7 | +57.14% | -2.88% | +0.69% | -3.58% | -1.85% | — |
| 14d | 7 | +57.14% | -5.72% | -0.42% | -5.30% | -1.55% | — |
| 30d | 7 | +42.86% | -0.60% | +0.10% | -0.70% | +7.55% | — |
| 60d | 7 | +85.71% | -6.64% | +3.75% | -10.38% | -7.01% | — |
| 90d | 7 | +85.71% | -19.93% | +4.22% | -24.15% | -22.37% | — |
| 180d | 7 | +71.43% | -17.20% | +7.16% | -24.36% | -25.24% | — |
| 1y | 7 | +100.00% | -32.47% | +17.35% | -49.81% | -48.41% | — |
| 2y | 7(7 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 25,000 | $10.00 | $250.0K | 12,176 | Jun 12, 2026 | Jun 12, 2026 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE Chief Commercial Officer | 25,000 | $1.50 | $37.5K | 37,176 | Jun 12, 2026 | Jun 12, 2026 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE Chief Commercial Officer | 25,000 | — | — | 519,588 | Jun 12, 2026 | Jun 12, 2026 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 240,000 | — | — | 240,000 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE Chief Commercial Officer | 15,000 | $1.50 | $22.5K | 25,315 | Jul 1, 2025 | Jul 3, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 15,000 | $16.99 | $254.9K | 10,315 | Jul 1, 2025 | Jul 3, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE Chief Commercial Officer | 15,000 | — | — | 544,588 | Jul 1, 2025 | Jul 3, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE Chief Commercial Officer | 15,000 | — | — | 559,588 | Jun 18, 2025 | Jun 20, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE Chief Commercial Officer | 15,000 | $1.50 | $22.5K | 22,696 | Jun 18, 2025 | Jun 20, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 15,000 | $16.00 | $240.0K | 7,696 | Jun 18, 2025 | Jun 20, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE Chief Commercial Officer | 10,000 | $1.50 | $15.0K | 17,696 | Mar 20, 2025 | Mar 21, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE Chief Commercial Officer | 10,000 | — | — | 574,588 | Mar 20, 2025 | Mar 21, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 10,000 | $14.00 | $140.0K | 7,696 | Mar 20, 2025 | Mar 21, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 152,300 | — | — | 152,300 | Jan 2, 2025 | Jan 3, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE Chief Commercial Officer | 6,283 | $1.50 | $9.4K | 11,976 | Dec 4, 2024 | Dec 4, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE Chief Commercial Officer | 6,283 | — | — | 584,588 | Dec 4, 2024 | Dec 4, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 6,283 | $14.00 | $88.0K | 5,693 | Dec 4, 2024 | Dec 4, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE Chief Commercial Officer | 3,717 | — | — | 590,871 | Dec 2, 2024 | Dec 4, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 3,717 | $14.11 | $52.5K | 5,693 | Dec 2, 2024 | Dec 4, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE Chief Commercial Officer | 3,717 | $1.50 | $5.6K | 9,410 | Dec 2, 2024 | Dec 4, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE Chief Commercial Officer | 10,000 | $1.50 | $15.0K | 15,693 | Sep 18, 2024 | Sep 19, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 10,000 | $14.00 | $140.0K | 5,693 | Sep 18, 2024 | Sep 19, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE Chief Commercial Officer | 10,000 | — | — | 594,588 | Sep 18, 2024 | Sep 19, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 10,000 | $14.00 | $140.0K | 5,693 | Aug 19, 2024 | Aug 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE Chief Commercial Officer | 10,000 | — | — | 604,588 | Aug 19, 2024 | Aug 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE Chief Commercial Officer | 10,000 | $1.50 | $15.0K | 15,693 | Aug 19, 2024 | Aug 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 50,000 | Jan 3, 2023 | Jan 5, 2023 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 614,588 | — | — | 614,588 | Nov 8, 2022 | Nov 10, 2022 ↗ | View → |